NCT04776577View on ClinicalTrials.gov

Assessment of Coronary Pressure Using the Combined Guidewire and Catheter Wirecath

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

October 25, 2021

Study Completion Date

October 25, 2021

Conditions
Coronary Disease
Interventions
DEVICE

Wirecath@ and Abbott PressureWire® (20 patients)

Simultaneous FFR measurements with Wirecath@ and Abbott PressureWire®

DEVICE

Wirecath® (20 patients)

FFR measurement with Wirecath® only

DEVICE

Coronary flow reserve

Pressure derived CFR with Wirecath®, Thermodilution CFR with Abbott PressureWire®, Absolut flow CFR with Abbott PressureWire® and Hexacath Rayflow catheter®, Non-invasive echo derived CFR

Trial Locations (1)

41345

Sahlgrenska University Hospital, Gothenburg

Sponsors

Collaborators (1)

Cavis Technologies AB
All Listed Sponsors
collaborator

Cavis Technologies AB

INDUSTRY

lead

Vastra Gotaland Region

OTHER_GOV

NCT04776577 - Assessment of Coronary Pressure Using the Combined Guidewire and Catheter Wirecath | Biotech Hunter | Biotech Hunter